Antiproliferative effect of CBS9106 on 60 human cancer cell lines in vitro
| . | IC50, nM . |
|---|---|
| CNS | |
| T98G | 33 |
| SK-N-AS | 28 |
| U-87 MG | 24 |
| BE(2)C | 19 |
| A172 | 16 |
| Head and neck | |
| FaDu | 64 |
| Cal 27 | 43 |
| Endocrine | |
| CAL-62 | 21 |
| CGTH-W-1 | 20 |
| Lung | |
| A427 | 46 |
| A549 | 37 |
| NCI-H460 | 29 |
| NCI-H661 | 21 |
| NCI-H292 | 10 |
| Breast | |
| Hs 578T | 112 |
| BT-549 | 98 |
| AU565 | 75 |
| MDA MB 453 | 17 |
| MDA MB 231 | 9 |
| Colon | |
| WiDr | 65 |
| HT-29 | 57 |
| SW48 | 49 |
| HCT-116 | 29 |
| DLD-1 | 26 |
| Pancreas | |
| PANC-1 | 84 |
| HuP-T4 | 57 |
| BxPC-3 | 50 |
| Mia PaCa-2 | 28 |
| Prostate | |
| BM-1604 | 126 |
| PC-3 | 28 |
| Kidney | |
| A498 | 42 |
| 786-O | 30 |
| G-401 | 11 |
| Caki-2 | 6 |
| 769-P | 3 |
| Liver | |
| HLE | 31 |
| HepG2 | 31 |
| HUH-6 Clone 5 | 28 |
| HLF | 27 |
| HuCCT1 | 16 |
| Female GU | |
| C-33A | 90 |
| SiHa | 42 |
| C-4 I | 41 |
| ES-2 | 21 |
| AN3 CA | 15 |
| Skin | |
| MeWo | 92 |
| CHL-1 | 49 |
| RPMI-7951 | 42 |
| HMCB | 31 |
| A375 | 10 |
| Soft tissue | |
| SK-UT-1 | 278 |
| SK-LMS-1 | 28 |
| HT-1080 | 19 |
| MES-SA | 15 |
| MG-63 | 14 |
| Bladder | |
| J82 | 146 |
| TCCSUP | 70 |
| BFTC-905 | 38 |
| UM-UC-3 | 33 |
| 639-V | 25 |
| . | IC50, nM . |
|---|---|
| CNS | |
| T98G | 33 |
| SK-N-AS | 28 |
| U-87 MG | 24 |
| BE(2)C | 19 |
| A172 | 16 |
| Head and neck | |
| FaDu | 64 |
| Cal 27 | 43 |
| Endocrine | |
| CAL-62 | 21 |
| CGTH-W-1 | 20 |
| Lung | |
| A427 | 46 |
| A549 | 37 |
| NCI-H460 | 29 |
| NCI-H661 | 21 |
| NCI-H292 | 10 |
| Breast | |
| Hs 578T | 112 |
| BT-549 | 98 |
| AU565 | 75 |
| MDA MB 453 | 17 |
| MDA MB 231 | 9 |
| Colon | |
| WiDr | 65 |
| HT-29 | 57 |
| SW48 | 49 |
| HCT-116 | 29 |
| DLD-1 | 26 |
| Pancreas | |
| PANC-1 | 84 |
| HuP-T4 | 57 |
| BxPC-3 | 50 |
| Mia PaCa-2 | 28 |
| Prostate | |
| BM-1604 | 126 |
| PC-3 | 28 |
| Kidney | |
| A498 | 42 |
| 786-O | 30 |
| G-401 | 11 |
| Caki-2 | 6 |
| 769-P | 3 |
| Liver | |
| HLE | 31 |
| HepG2 | 31 |
| HUH-6 Clone 5 | 28 |
| HLF | 27 |
| HuCCT1 | 16 |
| Female GU | |
| C-33A | 90 |
| SiHa | 42 |
| C-4 I | 41 |
| ES-2 | 21 |
| AN3 CA | 15 |
| Skin | |
| MeWo | 92 |
| CHL-1 | 49 |
| RPMI-7951 | 42 |
| HMCB | 31 |
| A375 | 10 |
| Soft tissue | |
| SK-UT-1 | 278 |
| SK-LMS-1 | 28 |
| HT-1080 | 19 |
| MES-SA | 15 |
| MG-63 | 14 |
| Bladder | |
| J82 | 146 |
| TCCSUP | 70 |
| BFTC-905 | 38 |
| UM-UC-3 | 33 |
| 639-V | 25 |
Results of multiplexed cytotoxicity assay on 60 cell lines. IC50 values for tumor growth inhibition are listed with mean values (n = 6).
GU indicates genitourinary; and CNS, central nervous system.